Skip to content
Save From Preventive Care. Vital Longevity.
  • Cardiovascular Metrics
    ViiV gains US approval for newborn HIV treatmentCardiovascular Metrics

    ViiV gains US approval for newborn HIV treatment

    August 29, 2026
    Isomab Shows Safe Blood Vessel Growth in CADCardiovascular Metrics

    Isomab Shows Safe Blood Vessel Growth in CAD

    August 29, 2026
  • Cellular Autophagy
    Biotech funding returns as bar risesCellular Autophagy

    Biotech funding returns as bar rises

    August 30, 2026
    Beyond Extravagance: A Royal Collection of Gems and JewelsCellular Autophagy

    Beyond Extravagance: A Royal Collection of Gems and Jewels

    August 28, 2026
  • Inflammation Triggers
    Unveiling the Marvel: How to Create Lab-Created DiamondsInflammation Triggers

    Unveiling the Marvel: How to Create Lab-Created Diamonds

    August 27, 2026
    Top Places for Custom Alexandrite Jewelry in GlasgowInflammation Triggers

    Top Places for Custom Alexandrite Jewelry in Glasgow

    August 26, 2026
  • Metabolic Markers
    Ionis wins approval for rare brain diseaseMetabolic Markers

    Ionis wins approval for rare brain disease

    September 4, 2026
    Akeso’s ivonescimab boosts survival in lung cancerMetabolic Markers

    Akeso’s ivonescimab boosts survival in lung cancer

    September 3, 2026
    PMV prepares to file first p53 cancer therapyMetabolic Markers

    PMV prepares to file first p53 cancer therapy

    September 2, 2026
    US Pharma Navigates Europe’s AI Regulatory MazeMetabolic Markers

    US Pharma Navigates Europe’s AI Regulatory Maze

    August 31, 2026
    Medizaa recently unveiled a strategy targeting the Indonesian marketMetabolic Markers

    Medizaa recently unveiled a strategy targeting the Indonesian market

    August 27, 2026
    Digital Health Pharmacy Practices IndonesiaMetabolic Markers

    Digital Health Pharmacy Practices Indonesia

    August 26, 2026
  • Sleep Architecture
    White House reaches deals with more pharmasSleep Architecture

    White House reaches deals with more pharmas

    September 1, 2026
    Rock the Ring, Rock the World: Finding an Ethical Engagement Ring that Makes a StatementSleep Architecture

    Rock the Ring, Rock the World: Finding an Ethical Engagement Ring that Makes a Statement

    August 27, 2026
    What Are the Benefits of Medicaid Member Engagement?Sleep Architecture

    What Are the Benefits of Medicaid Member Engagement?

    August 26, 2026
  • Cardiovascular Metrics
  • Cellular Autophagy
  • Inflammation Triggers
  • Metabolic Markers
  • Sleep Architecture
BREAKING NEWS
Ionis wins approval for rare brain disease Ionis wins approval for rare brain disease Akeso’s ivonescimab boosts survival in lung cancer Akeso’s ivonescimab boosts survival in lung cancer PMV prepares to file first p53 cancer therapy PMV prepares to file first p53 cancer therapy White House reaches deals with more pharmas White House reaches deals with more pharmas US Pharma Navigates Europe’s AI Regulatory Maze US Pharma Navigates Europe’s AI Regulatory Maze Biotech funding returns as bar rises Biotech funding returns as bar rises ViiV gains US approval for newborn HIV treatment ViiV gains US approval for newborn HIV treatment Isomab Shows Safe Blood Vessel Growth in CAD Isomab Shows Safe Blood Vessel Growth in CAD
Ionis wins approval for rare brain disease Ionis wins approval for rare brain disease Akeso’s ivonescimab boosts survival in lung cancer Akeso’s ivonescimab boosts survival in lung cancer PMV prepares to file first p53 cancer therapy PMV prepares to file first p53 cancer therapy White House reaches deals with more pharmas White House reaches deals with more pharmas US Pharma Navigates Europe’s AI Regulatory Maze US Pharma Navigates Europe’s AI Regulatory Maze Biotech funding returns as bar rises Biotech funding returns as bar rises ViiV gains US approval for newborn HIV treatment ViiV gains US approval for newborn HIV treatment Isomab Shows Safe Blood Vessel Growth in CAD Isomab Shows Safe Blood Vessel Growth in CAD
  1. Home
  2. /
  3. rare

Tag: rare

Ionis wins approval for rare brain disease
Metabolic Markers

Ionis wins approval for rare brain disease

Ionis wins approval for rare brain disease Alexander disease with antisense therapy Zanvastro providing treatment option.

By Ava Brown · Sep 4, 2026

Latest Post

  • Ionis wins approval for rare brain disease
  • Akeso’s ivonescimab boosts survival in lung cancer
  • PMV prepares to file first p53 cancer therapy
  • White House reaches deals with more pharmas
  • US Pharma Navigates Europe’s AI Regulatory Maze
  • Biotech funding returns as bar rises
  • ViiV gains US approval for newborn HIV treatment

About

  • About Us
  • Contact Us
  • Disclosure Policy
  • Sitemap
  • Terms of Service

Social Media

Facebook Facebook
YouTube YouTube
Twitter Twitter / X
Instagram Instagram

Save From

Preventive Care. Vital Longevity.

Categories

  • Cardiovascular Metrics
  • Cellular Autophagy
  • Inflammation Triggers
  • Metabolic Markers
  • Sleep Architecture

About

  • About Us
  • Contact Us
  • Disclosure Policy
  • Terms of Service
  • Sitemap

Latest post

  • Ionis wins approval for rare brain disease
  • Akeso’s ivonescimab boosts survival in lung cancer
  • PMV prepares to file first p53 cancer therapy
  • White House reaches deals with more pharmas
  • US Pharma Navigates Europe’s AI Regulatory Maze

© 2026 Save From. All rights reserved.

Theme by Auto UI Theme Builder.